Wei Luan

1.0k total citations
22 papers, 292 citations indexed

About

Wei Luan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wei Luan has authored 22 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Wei Luan's work include Metastasis and carcinoma case studies (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Wei Luan is often cited by papers focused on Metastasis and carcinoma case studies (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Wei Luan collaborates with scholars based in China, United States and Spain. Wei Luan's co-authors include Scott W. Lowe, John P. Morris, Yu-Jui Ho, Cassandra Burdziak, Richard P. Koche, Dana Pe’er, Nilgun Tasdemir, John E. Wilkinson, Hsuan-An Chen and Kaloyan M. Tsanov and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Wei Luan

17 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Luan China	8	145	137	93	62	39	22	292
Mara Persano Italy	6	126 0.9×	159 1.2×	84 0.9×	46 0.7×	25 0.6×	31	274
Betül Gök Yavuz United States	6	120 0.8×	172 1.3×	69 0.7×	137 2.2×	18 0.5×	12	325
Fangfang Bu China	8	173 1.2×	107 0.8×	90 1.0×	26 0.4×	26 0.7×	9	285
Jianmin Wu China	8	224 1.5×	123 0.9×	117 1.3×	74 1.2×	30 0.8×	13	354
Xiaoxue Ren China	6	234 1.6×	118 0.9×	133 1.4×	49 0.8×	39 1.0×	9	373
Lenka Bešše Switzerland	12	248 1.7×	121 0.9×	66 0.7×	56 0.9×	24 0.6×	39	399
Liling Qin China	10	136 0.9×	158 1.2×	127 1.4×	119 1.9×	35 0.9×	20	366
Yoshinari Atarashi Japan	8	179 1.2×	99 0.7×	59 0.6×	152 2.5×	21 0.5×	14	333
Ruiqi Wu China	6	149 1.0×	94 0.7×	79 0.8×	139 2.2×	28 0.7×	8	315
Yuyang Lin China	9	132 0.9×	154 1.1×	38 0.4×	170 2.7×	25 0.6×	11	378

Countries citing papers authored by Wei Luan

Since Specialization

Citations

This map shows the geographic impact of Wei Luan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Luan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Luan more than expected).

Fields of papers citing papers by Wei Luan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Luan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Luan. The network helps show where Wei Luan may publish in the future.

Co-authorship network of co-authors of Wei Luan

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Luan. A scholar is included among the top collaborators of Wei Luan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Luan. Wei Luan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Xu, Wei Luan, Yan Lv, et al.. (2025). The Circadian Transcription Factor CLOCK Modulates Oxidative Stress Resistance via the ACHL– Relish Axis in Drosophila. Advanced Science. 13(4). e14388–e14388.

Ren, Jiannan, Menglin Song, Dongbing Ding, et al.. (2025). Combined Oxaliplatin with 5-Fluorouracil for Effective Chemotherapy Against Gastric Cancer in Animal Model. International Journal of Nanomedicine. Volume 20. 7763–7780.

Zhang, Kai, et al.. (2024). Efficacy evaluation and survival analysis of the combination of oxaliplatin plus Teysuno (SOX) with immune checkpoint inhibitors in the conversion therapy of locally advanced gastric cancer. Oncology and Translational Medicine. 10(4). 190–197. 2 indexed citations

Su, Rina, et al.. (2024). MiR-340-5p affects the proliferation and transfer of gastric cancer cells by targeting lncRNA HCG11 and NRF2 expression. Oncology and Translational Medicine. 11(1). 29–35.

Katti, Alyna, Miguel Foronda, J. Lynn Zimmerman, et al.. (2023). Generation of precision preclinical cancer models using regulated in vivo base editing. Nature Biotechnology. 42(3). 437–447. 21 indexed citations

Tsanov, Kaloyan M., Francisco M. Barriga, Yu-Jui Ho, et al.. (2023). Abstract 3512: Organ-specific effects of Smad4 in metastatic pancreatic cancer. Cancer Research. 83(7_Supplement). 3512–3512.

Zhang, Kai, et al.. (2023). Recent advances in conversion therapy schemes for stage IV gastric cancer. Oncology and Translational Medicine. 9(5). 213–218. 1 indexed citations

Huang, Chun‐Hao, Francisco J. Sánchez‐Rivera, Margaret C. Kennedy, et al.. (2022). A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets. Proceedings of the National Academy of Sciences. 119(17). e2110557119–e2110557119. 8 indexed citations

Millman, Scott E., Almudena Chaves Perez, John P. Morris, et al.. (2022). Ogdh Is a Genetic Vulnerability and Therapeutic Target in Acute Myeloid Leukemia. Blood. 140(Supplement 1). 5846–5847. 1 indexed citations

10.

Zeng, Jiahui, et al.. (2021). Symptom trajectories and influencing factors of prostate cancer following radical prostatectomy in Chinese patients. Annals of Palliative Medicine. 10(7). 7747–7758. 2 indexed citations

11.

Alonso‐Curbelo, Direna, Yu-Jui Ho, Cassandra Burdziak, et al.. (2021). A gene–environment-induced epigenetic program initiates tumorigenesis. Nature. 590(7847). 642–648. 161 indexed citations

12.

Yu, Lan, et al.. (2021). CTCF-induced upregulation of LINC01207 promotes gastric cancer progression via miR-1301-3p/PODXL axis. Digestive and Liver Disease. 53(4). 486–495. 7 indexed citations

13.

Yu, Lan, Wei Luan, Jianchao Jia, et al.. (2020). Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769–5p. Digestive and Liver Disease. 53(2). 238–244. 10 indexed citations

14.

Wang, Qin, Wei Luan, Leslie Warren, et al.. (2016). Autologous Tumor Cell Lysate-Loaded Dendritic Cell Vaccine Inhibited Tumor Progression in an Orthotopic Murine Model for Hepatocellular Carcinoma. Annals of Surgical Oncology. 23(S5). 574–582. 16 indexed citations

15.

Wang, Qin, Seungyeul Yoo, Wenhui Wang, et al.. (2016). Impact of non-neoplastic vs intratumoural hepatitis B viral DNA and replication on hepatocellular carcinoma recurrence. British Journal of Cancer. 115(7). 841–847. 13 indexed citations

16.

Wang, Qin, Wei Luan, Leslie Warren, et al.. (2015). Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size. Journal of Immunotherapy. 39(1). 36–44. 13 indexed citations

17.

Wang, Qin, Maria Isabel Fiel, Wei Luan, et al.. (2015). The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma. Annals of Surgical Oncology. 22(S3). 1125–1132. 32 indexed citations

18.

Luan, Wei & Mei Bai. (2012). Role of JNK signaling pathway in sensitivity to radiotherapy of nasopharyngeal carcinoma. The Chinese-German Journal of Clinical Oncology. 11(5). 279–281.

19.

Luan, Wei, et al.. (2009). Role of integrin αV in sensitivity to radiotherapy of human NPC. The Chinese-German Journal of Clinical Oncology. 8(2). 86–89. 1 indexed citations

20.

Luan, Wei. (2000). Molecular Difference of Nucleotide Sequence of Main Regions of Glycoprotein Gene of Rabies Virus in China. Zhongguo shouyi xuebao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact